Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Levosimendan in Cardiac Surgery Patients
2011-002643-10Phase 4Completed
- Sponsor
- Tampere Heart Hospital
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in left ventricular dysfunction, aortic valve disease (AVD) and coronary arteriosclerosis, sponsored by Tampere Heart Hospital. Primary endpoint: Change in cardiac output after CPB. Started Dec 2011; status: completed.
02
Drugs
levosimendan
03
Conditions
left ventricular dysfunctionaortic valve disease (AVD)coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-002643-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002643-10.